Prevalence of Depressive Episodes with Psychotic Features in the General Population

Total Page:16

File Type:pdf, Size:1020Kb

Load more

Article Prevalence of Depressive Episodes With Psychotic Features in the General Population Maurice M. Ohayon, M.D., D.Sc., Objective: The study evaluated the prev- or guilt were also associated with high Ph.D. alence of major depressive episodes with rates of hallucinations (9.7%) and combi- psychotic features in the general popula- nations of hallucinations and delusions tion and sought to determine which de- (4.5%). The current prevalence of major Alan F. Schatzberg, M.D., Ph.D. pressive symptoms are most frequently depressive episode with psychotic fea- associated with psychotic features. tures was 0.4% (95% CI=0.35%–0.54%), Method: The sample was composed of and the prevalence of a current major de- 18,980 subjects aged 15–100 years who pressive episode without psychotic fea- were representative of the general popu- tures was 2.0% (95% CI=1.9%–2.1%), with lations of the United Kingdom, Germany, higher rates in women than in men. In all, Italy, Portugal, and Spain. The partici- 18.5% of the subjects who fulfilled the cri- pants were interviewed by telephone by teria for a major depressive episode had using the Sleep-EVAL system. The ques- psychotic features. Past consultations for tionnaire included a series of questions treatment of depression were more com- about depressive disorders, delusions, mon in depressed subjects with psychotic and hallucinations. features than in depressed subjects with no psychotic features. Results: Overall, 16.5% of the sample re- ported at least one depressive symptom Conclusions: Major depressive episodes at the time of the interview. Among these with psychotic features are relatively subjects, 12.5% had either delusions or frequent in the general population, af- hallucinations. More than 10% of the sub- fecting four of 1,000 individuals. Feelings jects who reported feelings of worthless- of worthlessness or guilt can be a good ness or guilt and suicidal thoughts also indicator of the presence of psychotic had delusions. Feelings of worthlessness features. (Am J Psychiatry 2002; 159:1855–1861) Depression is the most common mental disease and chotic features reported that the delusional patients were is the second leading cause of disability in Europe and the younger, more frequently had a past history of delusions, United States after heart diseases. Estimates of the previ- and more frequently had feelings of worthlessness (13). ous-year prevalence of major depressive disorders in the Another study did not find differences between psychotic general population have varied between 2.1% and 7.6%, and nonpsychotic depressed subjects in their clinical fea- and estimates of the previous-month prevalence have var- tures (age at onset, duration of the episode, frequency) ied between 1.5% and 6%, depending on the country stud- (14). In this study we report the prevalence of DSM-IV ma- ied and the classification system used (DSM-III, DSM-III- jor depressive episodes with and without psychotic fea- R, DSM-IV, or ICD-10) (1–8). However, these studies lim- tures in the general population of five Western European ited their analyses to broad diagnostic categories (major countries. We evaluated which depressive symptoms were depressive disorder and dysthymia) without describing more likely to be associated with psychotic features in the specifiers of the major depressive disorder. One study general population and the relative contributions of age, found that the lifetime prevalence of psychotic symptoms gender, and chronicity to the prevalence of major depres- in subjects who had ever met the criteria for major depres- sive episode with or without psychotic features. sion was 14% (0.6% lifetime prevalence of major depres- sive episode with psychotic features) (9). However, there Method are generally few data about the prevalence of associated psychotic features in subjects with major depressive disor- Sampling ders in the general population. A number of studies have The participants in the five countries were interviewed by tele- reported that psychotic depression differs from nonpsy- phone between 1994 and 1999 with the broader purpose of inves- tigating sleep habits, sleep-related symptoms, and psychiatric chotic depression in several respects (10–13). A clinical and sleep disorders (15). The United Kingdom, with approxi- study comparing patients with DSM-III-R major depres- mately 46 million inhabitants age 15 years or older, was the first sive disorder with psychotic features to those without psy- country to be studied in 1994. Germany, with 66 million inhabit- Am J Psychiatry 159:11, November 2002 1855 DEPRESSIVE EPISODES WITH PSYCHOTIC FEATURES ants age 15 years or older, was studied next in 1996; then Italy in occurrence of two diagnoses in accordance with the International 1997, with 46 million inhabitants 15 years or older; Portugal in Classification of Sleep Disorders and DSM-IV criteria. The inter- 1998, with 8 million inhabitants 18 years or older; and Spain in view ended once all diagnostic possibilities were exhausted. 1999, with 38.5 million inhabitants 15 years or older. (The mini- The system has been tested in various contexts; in clinical psy- mum age for Portugal was set at 18 years on the recommendation chiatry, overall agreement between the diagnoses of four psychia- of the ethics committee for the Portuguese survey.) The study was trists and those of the system ranged from 0.44 (kappa) with one approved by the ethical and research committee at the Canadian psychiatrist to 0.78 (kappa) with two psychiatrists (N=114 cases) university where the principal investigator (M.M.O.) was located (20). In another study that involved 91 forensic patients, most of at the time of the research and by ethics committees in each of the the patients (60%) met the criteria for a diagnosis in the psychosis countries where the surveys were conducted. The surveys were spectrum. The agreement between diagnoses obtained by the conducted with the help of the Teleperformance Group, a poll system and those given by psychiatrists was 0.44 (kappa) for spe- service company with several affiliates in Europe (British Poll Ser- cific psychotic disorders (mainly schizophrenia). Validation stud- vice [United Kingdom study], Teleperformance [German study], ies performed in sleep disorders clinics (Stanford University, Uni- Grandi Numeri [Italian and Spanish studies], and the poll com- versity of Regensburg, and Toronto Hospital) that tested the pany Action [Portugal]). All surveys were conducted under the su- diagnoses of the system against those of sleep specialists who pervision of the principal investigator (M.M.O.). used polysomnographic data gave kappas between 0.71 and 0.93 The target population was all noninstitutionalized residents for different sleep disorders (21, 22). age 15 years or older (or 18 years or older for Portugal). The same The duration of the interviews ranged from 10 to 333 minutes, two-stage sampling strategy was used for all five countries. In the with an average of 40 minutes (SD=20 minutes). The longest in- first stage, the population was divided by geographical distribu- terviews involved subjects with multiple sleep and mental disor- tion according to the official census data for each country, and ders. Interviews were completed over two or more sessions if the then telephone numbers were randomly drawn. In the second duration exceeded 60 minutes. stage, within each sampled household a member was selected as a function of age and gender by using the Kish method (16) to Variables maintain the representativeness of the sample and to avoid bias The exploration of depression began with questions assessing related to noncoverage error. whether the subject 1) was feeling sad, downcast, or depressed; Participants had to first grant their verbal consent before pro- 2) was feeling hopeless; and 3) had lost interest or lacked pleasure ceeding with the interview. For subjects younger than 18 years of in activities formerly considered pleasant. The subjects were age, the verbal consent of the parents was also requested. We ex- asked to rate these symptoms on an intensity scale (extremely, a cluded potential participants who had insufficient fluency in the lot, moderately, slightly, not at all, does not know) and asked national language, who had a hearing or speech impairment, or whether each symptom was present most of the day and nearly who had an illness that made an interview infeasible. every day. Subjects who answered positively to one of these The participation rate was 79.6% (4,972 of 6,249 eligible individ- symptoms were asked another series of questions that assessed uals) in the United Kingdom; 68.1% (4,115 of 6,047 eligible individ- 1) changes in appetite or weight; 2) insomnia or hypersomnia uals) in Germany; 89.4% (3,970 of 4,442 eligible individuals) in It- symptoms; 3) psychomotor agitation or retardation; 4) fatigue or aly; 83.1% (1,858 of 2,234 eligible subjects) in Portugal; and 87.5% loss of energy; 5) feelings of worthlessness or guilt; 6) difficulties (4,065 of 4,648 eligible individuals) in Spain. Overall, 18,980 sub- in concentration or thinking and difficulties making decisions; jects participated in the study. The overall participation rate was and 7) suicidal ideation. These symptoms were rated by the sub- 80.4%. This sample was representative of 205,890,882 inhabitants. jects on the same intensity scale that was used for the initial symptoms, and the subjects were asked whether the symptom Instrument was present most of the day and nearly every day. The subjects The Sleep-EVAL expert system (17, 18), software developed by also reported how long they had experienced depressive mood. the principal investigator (M.M.O.) to conduct epidemiological The subjects were also asked about current and past use of an- studies in the general population and to administer question- tidepressant medication and whether they were currently con- naires, was used to perform the interviews.
Recommended publications
  • Is Your Depressed Patient Bipolar?

    Is Your Depressed Patient Bipolar?

    J Am Board Fam Pract: first published as 10.3122/jabfm.18.4.271 on 29 June 2005. Downloaded from EVIDENCE-BASED CLINICAL MEDICINE Is Your Depressed Patient Bipolar? Neil S. Kaye, MD, DFAPA Accurate diagnosis of mood disorders is critical for treatment to be effective. Distinguishing between major depression and bipolar disorders, especially the depressed phase of a bipolar disorder, is essen- tial, because they differ substantially in their genetics, clinical course, outcomes, prognosis, and treat- ment. In current practice, bipolar disorders, especially bipolar II disorder, are underdiagnosed. Misdi- agnosing bipolar disorders deprives patients of timely and potentially lifesaving treatment, particularly considering the development of newer and possibly more effective medications for both depressive fea- tures and the maintenance treatment (prevention of recurrence/relapse). This article focuses specifi- cally on how to recognize the identifying features suggestive of a bipolar disorder in patients who present with depressive symptoms or who have previously been diagnosed with major depression or dysthymia. This task is not especially time-consuming, and the interested primary care or family physi- cian can easily perform this assessment. Tools to assist the physician in daily practice with the evalua- tion and recognition of bipolar disorders and bipolar depression are presented and discussed. (J Am Board Fam Pract 2005;18:271–81.) Studies have demonstrated that a large proportion orders than in major depression, and the psychiat- of patients in primary care settings have both med- ric treatments of the 2 disorders are distinctly dif- ical and psychiatric diagnoses and require dual ferent.3–5 Whereas antidepressants are the treatment.1 It is thus the responsibility of the pri- treatment of choice for major depression, current mary care physician, in many instances, to correctly guidelines recommend that antidepressants not be diagnose mental illnesses and to treat or make ap- used in the absence of mood stabilizers in patients propriate referrals.
  • The Implications of Hypersomnia in the Context of Major Depression: Results from a Large, International, Observational Study

    The Implications of Hypersomnia in the Context of Major Depression: Results from a Large, International, Observational Study

    ARTICLE IN PRESS JID: NEUPSY [m6+; March 2, 2019;10:45 ] European Neuropsychopharmacology (2019) 000, 1–11 www.elsevier.com/locate/euroneuro The implications of hypersomnia in the context of major depression: Results from a large, international, observational study a a, b c a A. Murru , G. Guiso , M. Barbuti , G. Anmella , a, d ,e a ,f , g g h N. Verdolini , L. Samalin , J.M. Azorin , J. Jules Angst , i j k a, l C.L. Bowden , S. Mosolov , A.H. Young , D. Popovic , m c a, ∗ a M. Valdes , G. Perugi , E. Vieta , I. Pacchiarotti , For the BRIDGE-II-Mix Study Group a Barcelona Bipolar and Depressive Disorders Unit, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain b Clinica Psichiatrica, Dipartimento di Igiene e Sanità, Università di Cagliari, Italy c Division of Psychiatry, Clinical Psychology and Rehabilitation, Department of Medicine, University of Perugia, Santa Maria della Misericordia Hospital, Edificio Ellisse, 8 Piano, Sant’Andrea delle Fratte, 06132, Perugia, Italy d FIDMAG Germanes Hospitalàries Research Foundation, Sant Boi de Llobregat, Barcelona, Catalonia, Spain e Division of Psychiatry, Clinical Psychology and Rehabilitation, Department of Medicine, Santa Maria della Misericordia Hospital, University of Perugia, Perugia, Italy f CHU Clermont-Ferrand, Department of Psychiatry, University of Auvergne, Clermont-Ferrand, France g Fondation FondaMental, Hôpital Albert Chenevier, Pôle de Psychiatrie, Créteil, France h Department of Psychiatry, Psychotherapy and Psychosomatics,
  • Major Depressive Episode

    Major Depressive Episode

    Molina Healthcare Coding Education Major Depressive Episode Documentation Examples: Initial Diagnosis: 65 year old Latina presenting with new onset depressive symptoms for past 2 months including daily depressed mood, loss of energy and inability to concentrate. PHQ9 score of 12 (moderate depression). Assessment: Patent is newly diagnosed with major depression, single episode, moderate; needing medical and cognitive therapy Accurately diagnosing Major Depression requires distinguishing between a single depressive episode Plan: Start Citalopram 20 mg and refer for psychotherapy and recurrent depression. Hence, it is necessary to ICD-10 Code: F32.1 Major Depressive Disorder, single episode, moderate identify and document the manifestations of the disease burden. Another key consideration is noting OR the term “chronic” can apply to both recurrent and Initial Diagnosis: single depressive episodes. A single or first time event should be coded as F32.0-F32.9 (severity 73 year old female with many known episodes of Major specification required) and any patient who has Depression now complaining of worsening symptoms experienced subsequent episodes should be coded as including increased loss of interest in activities, hypersomnia, increased tearfulness and sadness. Denies F33.9. thoughts of self-harm ICD-10: F32.0-F32.5 Major Depressive Disorder, Assessment: Patient diagnosed with Major Depression, recurrent, single episode, specifier required (e.g., mild; unspecified; currently symptoms not controlled moderate; severe with or without psychotic Plan: Increase SSRI dosage and close follow- up recommended symptoms; in partial or full remission) ICD-10 Code: F33.9, Major Depressive Disorder, OR recurrent, unspecified ICD-10: F33.9 Major Depressive Disorder, recurrent, unspecified The Patient Health Questionnaire-9 (PHQ-9) is a multipurpose instrument for screening, diagnosing, monitoring and measuring the severity of depression.
  • Depression Treatment Guide DSM V Criteria for Major Depressive Disorders

    Depression Treatment Guide DSM V Criteria for Major Depressive Disorders

    MindsMatter Ohio Psychotropic Medication Quality Improvement Collaborative Depression Treatment Guide DSM V Criteria for Major Depressive Disorders A. Five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Note: Do not include symptoms that are clearly attributable to another medical condition. 1) Depressed mood most of the day, nearly every day, as 5) Psychomotor agitation or retardation nearly every day indicated by either subjec tive report (e.g., feels sad, empty, (observable by others, not merely subjective feelings of hopeless) or observation made by others (e.g., appears restlessness or being slowed down). tearful). (Note: In children and adolescents, can be irritable 6) Fatigue or loss of energy nearly every day. mood.) 7) Feelings of worthlessness or excessive or inappropriate 2) Markedly diminished interest or pleasure in all, or almost all, guilt (which may be delu sional) nearly every day (not activities most of the day, nearly every day (as indicated by merely self-reproach or guilt about being sick). either subjective account or observation). 8) Diminished ability to think or concentrate, or 3) Significant weight loss when not dieting or weight gain indecisiveness, nearly every day (ei ther by subjective (e.g., a change of more than 5% of body weight in a account or as observed by others). month}, or decrease or increase in appetite nearly every day. (Note: In children, consider failure to make expected 9) Recurrent thoughts of death (not just fear of dying), weight gain.) recurrent suicidal ideation with out a specific plan, or a suicide attempt or a specific plan for committing suicide.
  • Mood Disorders Agenda

    Mood Disorders Agenda

    Mood Disorders Agenda • Statistics on MDD • Mood Disorders • Major Depressive Disorder • Bipolar • Schizophrenia • Other Mood Disorders Statistics The National Institute of Mental Health (NIMH) conservatively estimates the total costs associated with serious mental illness, those disorders that are severely debilitating and affect about 6 percent of the adult population, to be in excess of $300 billion per year. This estimate is based on 2002 data from the Substance Abuse and Mental Health Services Administration (SAMHSA) , the Social Security Administration , and findings from the NIMH-funded National Comorbidity Survey – Replication (NCS-R) The prevalence of a major mood disorder (Depression, BPD) in a given year in the Medicare population is only ~5% but the lifetime prevalence of a major mood disorder is ~20%.1 1According to the NIH the one year prevalence of a major depressive episode (not BPD) is anywhere from 5-16% depending on the patient’s age with younger patients having a higher prevalence in any given year. Since the diagnosis of “Major Depression in Remission” considers the lifetime prevalence the figure most likely exceeds 20% for all mood disorders combined. Major Depressive Disorder (MDD) According to the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM‐5) , five or more of the symptoms listed below must be present during the same 2-week time period that represents changes in functioning. At least one symptom is either a depressed mood or loss of interest. Depressed mood most of the day,
  • Psychosis in Children and Adolescents

    Psychosis in Children and Adolescents

    PSYCH TLC DEPARTMENT OF PSYCHIATRY DIVISION OF CHILD & ADOLESCENT PSYCHIATRY UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES PSYCHIATRIC RESEARCH INSTITUTE Psychosis in Children and Adolescents Written by: Jody L. Brown, M.D. Assistant Professor D. Alan Bagley, M.D. Chief Resident Department of Psychiatry Division of Child & Adolescent Psychiatry University of Arkansas for Medical Sciences Initial Review by: Laurence Miller, M.D. Clinical Professor, Medical Director, Division of Behavioral Health Services Arkansas Department of Human Services Initially Developed: 1-31-2012 Updated 3-31-2014 by: Angela Shy, MD Assistant Professor Department of Psychiatry Division of Child & Adolescent Psychiatry University of Arkansas for Medical Sciences Work submitted by Contract # 4600016732 from the Division of Medical Services, Arkansas Department of Human Services 1 | P a g e Department of Human Services Psych TLC Phone Numbers: 501-526-7425 or 1-866-273-3835 The free Child Psychiatry Telemedicine, Liaison & Consult (Psych TLC) service is available for: Consultation on psychiatric medication related issues including: . Advice on initial management for your patient . Titration of psychiatric medications . Side effects of psychiatric medications . Combination of psychiatric medications with other medications Consultation regarding children with mental health related issues Psychiatric evaluations in special cases via tele-video Educational opportunities This service is free to all Arkansas physicians caring for children. Telephone consults are made within 15 minutes of placing the call and can be accomplished while the child and/or parent are still in the office. Arkansas Division of Behavioral Health Services (DBHS): (501) 686-9465 http://humanservices.arkansas.gov/dbhs/Pages/default.aspx 2 | P a g e Table of Contents 1.
  • Treating Major Depressive Disorder: a Quick Reference Guide

    Treating Major Depressive Disorder: a Quick Reference Guide

    Treating Major Depressive Disorder A Quick Reference Guide Based on Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Third Edition, originally published in October 2010. A guideline watch, summarizing significant developments in the scientific literature since publication of this guideline, may be available. 1 2 Treating Major Depressive Disorder INTRODUCTION Treating Major Depressive Disorder: A Quick Reference Guide is a synopsis of the American Psychiatric Association’s Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Third Edition, Part A of which was originally published in The American Jour- nal of Psychiatry in October 2010 and is available through American Psychiatric Publishing, Inc. The psychiatrist using this Quick Refer- ence Guide (QRG) should be familiar with the full-text practice guide- line on which it is based. The QRG is not designed to stand on its own and should be used in conjunction with the full-text practice guide- line. For clarification of a recommendation or for a review of the ev- idence supporting a particular strategy, the psychiatrist will find it helpful to return to the full-text practice guideline. STATEMENT OF INTENT The Practice Guidelines and the Quick Reference Guides are not in- tended to be construed or to serve as a standard of medical care. Standards of medical care are determined on the basis of all clinical data available for an individual patient and are subject to change as scientific knowledge and technology advance and practice patterns evolve. These parameters of practice should be considered guide- lines only. Adherence to them will not ensure a successful outcome for every individual, nor should they be construed as including all proper methods of care or excluding other acceptable methods of care aimed at the same results.
  • Bipolar Disorder Diagnostic Criteria

    Bipolar Disorder Diagnostic Criteria

    Bipolar Disorder Diagnostic Criteria To meet the criteria for bipolar I disorder a person must meet both A and B: A. Criteria met for at least one manic episode (criteria A-D under manic episode below) B. There is not a better explanation for the manic episode or major depressive episode in another diagnosis. For example: • Schizoaffective disorder • Schizophrenia • Schizophreniform disorder • Delusional disorder • Other specified or unspecified schizophrenia spectrum • Other psychotic disorder Note: a hypomanic episode may occur before or after a manic or major depressive episode. Bipolar Disorder Diagnostic Criteria 1 Manic episode criteria Criteria Symptoms A. Lasts at least one week, or Abnormal and persistent extreme expression of emotion or irritable mood and any length if hospitalized due abnormal and persistent increase in activity or energy to mania B. During criteria A • Inflated self-esteem and grandiosity symptoms, three or more of • Decrease in need for sleep these symptoms (four if mood is only irritable) • More talkative than baseline or fast talking • Flight of ideas or subjective experience that thoughts are racing • Distractibility (reported or seen) • Increase in goal-directed activity (socially, at work, school or sexually) or movements that serve no purpose • Excessive engagement in activities with high risk of painful results (e.g., unrestrained buying sprees, sexual indiscretions or foolish business investments) C. Mood disturbance severity • Causes marked impairment in social or occupational functioning or • Requires hospitalization to prevent harm or • There are psychotic traits D. Differential diagnosis • Substance use and medical causes are ruled out Bipolar 1 disorder (1) Major depressive episode criteria Note: Criteria A-C form a major depressive episode • Major depressive episodes are common in bipolar 1 disorder.
  • Schizoaffective Disorder?

    Schizoaffective Disorder?

    WHAT IS SCHIZOAFFECTIVE DISORDER? BASIC FACTS • SYMPTOMS • FAMILIES • TREATMENTS RT P SE A Mental Illness Research, Education and Clinical Center E C I D F I A C VA Desert Pacific Healthcare Network V M R E E Long Beach VA Healthcare System N T T N A E L C IL L LN A E IC S IN Education and Dissemination Unit 06/116A S R CL ESE N & ARCH, EDUCATIO 5901 E. 7th street | Long Beach, CA 90822 basic facts Schizoaffective disorder is a chronic and treatable psychiatric Causes illness. It is characterized by a combination of 1) psychotic symp- There is no simple answer to what causes schizoaffective dis- toms, such as those seen in schizophrenia and 2) mood symptoms, order because several factors play a part in the onset of the dis- such as those seen in depression or bipolar disorder. It is a psychi- order. These include a genetic or family history of schizoaffective atric disorder that can affect a person’s thinking, emotions, and be- disorder, schizophrenia, or bipolar disorder, biological factors, en- haviors and can impact all aspects of daily living, including work, vironmental stressors, and stressful life events. school, social relationships, and self-care. Research shows that the risk of schizoaffective disorder re- Schizoaffective disorder is considered a psychotic disorder sults from the influence of genes acting together with biological because of its prominent features of hallucinations and delusions. and environmental factors. A family history of schizoaffective dis- Therefore, people with this illness have periods when they have order does not necessarily mean children or other relatives will difficulty understanding the reality around them.
  • The Implications of Hypersomnia in the Context of Major Depression: Results from a Large, International, Observational Study

    The Implications of Hypersomnia in the Context of Major Depression: Results from a Large, International, Observational Study

    European Neuropsychopharmacology (2019) 29, 471–481 www.elsevier.com/locate/euroneuro The implications of hypersomnia in the context of major depression: Results from a large, international, observational study a a, b c a A. Murru , G. Guiso , M. Barbuti , G. Anmella , a, d ,e a ,f , g g h N. Verdolini , L. Samalin , J.M. Azorin , J. Jules Angst , i j k a, l C.L. Bowden , S. Mosolov , A.H. Young , D. Popovic , m c a, ∗ a M. Valdes , G. Perugi , E. Vieta , I. Pacchiarotti , For the BRIDGE-II-Mix Study Group a Barcelona Bipolar and Depressive Disorders Unit, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain b Clinica Psichiatrica, Dipartimento di Igiene e Sanità, Università di Cagliari, Italy c Division of Psychiatry, Clinical Psychology and Rehabilitation, Department of Medicine, University of Perugia, Santa Maria della Misericordia Hospital, Edificio Ellisse, 8 Piano, Sant’Andrea delle Fratte, 06132, Perugia, Italy d FIDMAG Germanes Hospitalàries Research Foundation, Sant Boi de Llobregat, Barcelona, Catalonia, Spain e Division of Psychiatry, Clinical Psychology and Rehabilitation, Department of Medicine, Santa Maria della Misericordia Hospital, University of Perugia, Perugia, Italy f CHU Clermont-Ferrand, Department of Psychiatry, University of Auvergne, Clermont-Ferrand, France g Fondation FondaMental, Hôpital Albert Chenevier, Pôle de Psychiatrie, Créteil, France h Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich,
  • Major Depression and Dysthymic Disorder in Adolescents: the Critical Role of School Counselors

    Major Depression and Dysthymic Disorder in Adolescents: the Critical Role of School Counselors

    VISTAS Online VISTAS Online is an innovative publication produced for the American Counseling Association by Dr. Garry R. Walz and Dr. Jeanne C. Bleuer of Counseling Outfitters, LLC. Its purpose is to provide a means of capturing the ideas, information and experiences generated by the annual ACA Conference and selected ACA Division Conferences. Papers on a program or practice that has been validated through research or experience may also be submitted. This digital collection of peer-reviewed articles is authored by counselors, for counselors. VISTAS Online contains the full text of over 500 proprietary counseling articles published from 2004 to present. VISTAS articles and ACA Digests are located in the ACA Online Library. To access the ACA Online Library, go to http://www.counseling.org/ and scroll down to the LIBRARY tab on the left of the homepage. n Under the Start Your Search Now box, you may search by author, title and key words. n The ACA Online Library is a member’s only benefit. You can join today via the web: counseling.org and via the phone: 800-347-6647 x222. Vistas™ is commissioned by and is property of the American Counseling Association, 5999 Stevenson Avenue, Alexandria, VA 22304. No part of Vistas™ may be reproduced without express permission of the American Counseling Association. All rights reserved. Join ACA at: http://www.counseling.org/ Suggested APA style reference: Zalaquett, C. P., & Sanders, A. E. (2010). Major depression and dysthymic disorder in adolescents: The critical role of school counselors. Retrieved from http://counselingoutfitters.com/vistas/vistas10/Article_77.pdf Article 77 Major Depression and Dysthymic Disorder in Adolescents: The Critical Role of School Counselors Carlos P.
  • Diagnostic Criteria for Major Depressive Disorder and Depressive Episodes

    Diagnostic Criteria for Major Depressive Disorder and Depressive Episodes

    Diagnostic Criteria for Major Depressive Disorder and Depressive Episodes DSM-IV Criteria for Major Depressive Disorder (MDD) • Depressed mood or a loss of interest or pleasure in daily activities for more than two weeks. • Mood represents a change from the person's baseline. • Impaired function: social, occupational, educational. • Specific symptoms, at least 5 of these 9, present nearly every day: 1. Depressed mood or irritable most of the day, nearly every day, as indicated by either subjective report (e.g., feels sad or empty) or observation made by others (e.g., appears tearful). 2. Decreased interest or pleasure in most activities, most of each day 3. Significant weight change (5%) or change in appetite 4. Change in sleep: Insomnia or hypersomnia 5. Change in activity: Psychomotor agitation or retardation 6. Fatigue or loss of energy 7. Guilt/worthlessness: Feelings of worthlessness or excessive or inappropriate guilt 8. Concentration: diminished ability to think or concentrate, or more indecisiveness 9. Suicidality: Thoughts of death or suicide, or has suicide plan DSM – V proposed (not yet adopted) anxiety symptoms that may indicate depression: irrational worry, preoccupation with unpleasant worries, trouble relaxing, feeling tense, fear that something awful might happen. Screen for conditions that may mimic or co exist with Major Depressive Disorder: • Substance abuse causing depressed mood (eg. drugs, alcohol, medications) • Medical illness causing depressed mood • Other psychiatric disorders: mania, hypomania, bipolar, schizoaffective,